advertisement
advertisement
advertisement
  • 11.09.16

Pharma stocks are up in the wake of a Trump win 

Investors’ fears about the next administration cracking down on the practice of “price hiking”—drug companies dramatically pushing up costs for life-saving medications—seem to have dissipated in the wake of a Trump win. Pharma and biotech stocks climbed today for giants like Merck and Pfizer. 

Trump did speak out about this issue during his campaign, but he didn’t specifically put forward any measures as Clinton did. CF